An intravenous formulation of cultured adult human mesenchymal stem cells proposed to treat acute and steroid-refractory graft-versus-host disease in patients who have undergone allogeneic hematopoietic stem cell transplantation.
If you have a Hayes login, click here to view the full report on the Knowledge Center.